| Tag | Content |
|---|
EnhancerAtlas ID | HS145-12933 |
Organism | Homo sapiens |
Tissue/cell | NHBE |
Coordinate | chr2:98582920-98583810 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr2:98583484-98583496 | AAACAAACAAAC | - | 6.32 | | Foxd3 | MA0041.1 | chr2:98583488-98583500 | AAACAAACAAAC | - | 6.32 | | Foxd3 | MA0041.1 | chr2:98583492-98583504 | AAACAAACAAAC | - | 6.32 | | Foxd3 | MA0041.1 | chr2:98583496-98583508 | AAACAAACAAAC | - | 6.32 | | Foxd3 | MA0041.1 | chr2:98583500-98583512 | AAACAAACAAAC | - | 6.32 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_11250 | chr2:98573319-98587505 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I097966 | chr2 | 98583264 | 98583590 |
|
Enhancer Sequence | TAAAAGGTAT AAACTACTTG AGGCCAGGAA TCACCCCTTC TTCATCTCTT AGGTTCCAAC 60
GACCAATCCA GTGTCTGACA CAGTGGCCCT CAATAAATGT TTGTTGAGCT GACTACATGG 120
ATTACCTTCA GACTAAGGAG TTGGTCTGGT CCAACTGAAA ATAGCTTCAA GTTGGCTCAC 180
CTGGGATTAC ACAAGTAGTC CAGAGTCAAA CATAACATGA ATATGCAACA AGAGCTAGCA 240
CTAATCCAGC ACTTACTACA TACCAAGCCC TACAGATGAT TCAATACTCA CACCAACCCT 300
AGAAGACAGG TATTCCTATT ATCCCCATTA AACAAATTAG GAAGCTGACA CATGAGGACT 360
AGTTAACTTG CTCAAGGTCA CAGTCAAGCC CATATTCCAA GTCAGCAGTC TGTTTACTCT 420
CTACACCACT GAGAAAGGTA GCCAGGCAGG TCCCTCATAT AAGATGACAA GACTAATCAC 480
TTACGAAGAC AAGCCCTTGC TTTGACCAAA CTTGTTCCAG GGGTGTTCAC AGGTGTGAAT 540
TCAACCACAC CTGCCCACCA CCTAAAACAA ACAAACAAAC AAACAAACAA ACGGCACACT 600
TCTTAGATGG GGGCGGTGAG TCAGATGGAA CTTATGGAGT ATTGTTTTGA CTCACCATAA 660
AAGGGAGTTA CTCAGATCCA GACCTAATGC CCCATTAGAA CTGTCCTCTC TAATTTCATA 720
AGCTGACTGA TACACAGGTC TGTGTATACA GTCAACCTAG CTCTCTCCTG TGGCACACAC 780
ATATTAATAT GTACCTTTAA TCTTACACTG TAATTGTTTA TGCCTGTCTC TAACAAAAAA 840
ATTCTTGGAA GCTAATTACT ATCTTACTCA TAAACATATC CAAGGACCCA 890
|
